Skip to content

Evaluation of Sublingual Microcirculation in Burn During Resuscitation

The Evaluation of Sublingual Microcirculation To Guide Fluid Resuscitation In Patients With Burn: Prospective Observational Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05096559
Enrollment
30
Registered
2021-10-27
Start date
2021-02-01
Completion date
2022-02-01
Last updated
2021-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn Shock

Brief summary

The adequacy of fluid resuscitation will be monitored in burn patients using microcirculation. Microcirculation camera will be placed on the base of the tongue and at different four quadrants. • Microcirculation parameters at baseline and after 8h , 16h and 24h of fluid resuscitation will be recorded. Fluid resuscitation with lactated ringer according to Parkland formula (4 ml/kg/%TBSA) 50% given during the first 8 hours, with the remainder given during the following 16 hours, will be initiated to maintain a urinary output of 0.5ml/kg/hr.Norepinephrine infusion will be started in case of circulatory failure at a rate of 0.02mic/kg/min to maintain MAP of 65-70mmHg.

Interventions

DEVICEMicrocirculation cytocam

Visualization of tongue microcirculation

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age more than 18 years old * Burn \>20% TBSA * Patients with burn admitted within the 1st 6 hours

Exclusion criteria

* Age \< 18 years old. * Pregnant patients. * Patients with severe renal insufficiency. * Patients shocked due to other causes as sepsis, hypovolaemia or cardiogenic shock * Patients with airway edema that preclude the measurement of sublingual microcirculation

Design outcomes

Primary

MeasureTime frameDescription
• Lactate level24 hoursmmol/L

Secondary

MeasureTime frameDescription
total vessel density24 hoursmm/mm2

Countries

Egypt

Contacts

Primary ContactShymaa Fathy, MD
angel6122003@yahoo.com+201000455897
Backup ContactShymaa Mahmoud, MMSc
dr_shoshomahmoud2003@yahoo.com0106469416

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026